1. Home
  2. FEIM vs FDMT Comparison

FEIM vs FDMT Comparison

Compare FEIM & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frequency Electronics Inc.

FEIM

Frequency Electronics Inc.

HOLD

Current Price

$57.52

Market Cap

439.6M

Sector

Industrials

ML Signal

HOLD

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$9.22

Market Cap

479.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEIM
FDMT
Founded
1961
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
439.6M
479.9M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
FEIM
FDMT
Price
$57.52
$9.22
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$51.50
$31.71
AVG Volume (30 Days)
134.4K
598.4K
Earning Date
03-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
316.95
18.79
EPS
0.41
N/A
Revenue
$69,811,000.00
$85,209,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$21.73
$70.28
P/E Ratio
$146.74
N/A
Revenue Growth
26.30
230194.60
52 Week Low
$17.56
$3.37
52 Week High
$64.99
$12.34

Technical Indicators

Market Signals
Indicator
FEIM
FDMT
Relative Strength Index (RSI) 52.59 44.50
Support Level $42.53 $8.45
Resistance Level $59.75 $9.78
Average True Range (ATR) 4.20 0.61
MACD 0.35 -0.01
Stochastic Oscillator 60.10 23.74

Price Performance

Historical Comparison
FEIM
FDMT

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: